New insights on safety, adherence, and patient satisfaction with ESO-101 to be presented on May 3, 2025, at DDW 2025. ESO-101 features EsoCap’s proprietary drug delivery technology to enable localized…
Detailed results of the ACESO Phase II study published in the peer-reviewed medical journal Alimentary Pharma-cology & Therapeutics ESO-101 leverages EsoCap’s unique drug delivery technology to achieve localized treatment of…
EsoCap has announced that scientists at the University of Greifswald have published important data on a hot-melt extrusion-based spinning process for the production of drug-loaded pharmaceutical fibres and yarns. The…
EsoCap has announced that scientists at the University of Greifswald have published highly relevant data based on further work with the EsoPeriDiss release model. The EsoCap device enables the targeted…
EsoCap has announced that scientists from the University of Greifswald have published highly promising data for the development of RNA drugs for localized use in the oesophagus, utilizing the EsoCap…
The article in the latest issue of Fette Compacting's customer magazine "What's Next" provides an insightful overview of the development of a component, a sinker (placebo tablet) to increase the…
EsoCap CEO interviewed by CCFA as part of International Women's Day. "I am very pleased to have been selected to give an interview in Caléidoscope, the journal of the CCFA…
Malzgasse 9, CH-4052 Basel
